Dhaka, April 30 -- Bangladesh's pharmaceutical sector stands at the brink of becoming a global powerhouse, but experts warn that regulatory, infrastructural, and strategic complexities must be swiftly addressed to fully harness its potential.
Dr. Lakiot Ullah, Managing Director of Bio Pharma Limited, a prominent industry expert told The New Nation that despite significant progress, several systemic challenges threaten to limit the industry's expansion.
Regulatory delays, lack of skilled human resources, insufficient research and innovation, and infrastructural gaps have emerged as major bottlenecks.
He stressed that strategic reforms, particularly in ensuring global-standard quality compliance and boosting the production of Active Pharma...